Pediatric emergency medicine trisk 4587 4587
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (73.81 KB, 1 trang )
Christopher GW, Cieslak TJ, Pavlin JA, et al. Biological warfare: a historical
perspective. JAMA 1997;278:412–417.
Fine AM, Wong JB, Fraser HS, et al. Is it influenza or anthrax? A decision
analytic approach to the treatment of patients with influenza-like illness. Ann
Emerg Med 2004;43:318–328.
Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and
management of patients exposed to biological warfare agents. JAMA
1997;278:399–411.
Henretig FM, Cieslak TJ, Kortepeter MG, et al. Medical management of the
suspected victim of bioterrorism: an algorithmic approach to the
undifferentiated patient. Emerg Med Clin North Am 2002;20:351–364.
White S, Henretig F, Dukes R. Vulnerable populations in the setting of
bioterrorism. Emerg Med Clin North Am 2002;20:365–392.
Chemical Terrorism
Brennan RJ, Waeckerle JF, Sharp T, et al. Chemical warfare agents: emergency
medical and emergency public health issues. Ann Emerg Med 1999;34:191–
204.
Occupational Safety and Health Administration. OSHA best practices for
hospital-based first receivers of victims from mass casualty incidents involving
the
release
of
hazardous
substances.
Available
online
at
/>Rotenberg JS, Newmark J. Nerve agent attacks on children: diagnosis and
management. Pediatrics 2003;112:648–658.
Sofer S, Tal A, Shahak E. Carbamate and organophosphate poisoning in early
childhood. Pediatr Emerg Care 1989;5:222–225.
Yu CE, Burklow TR, Madsen JM. Vesicant agents and children. Pediatr Ann
2003;32:254–257.
____________
*
The views, opinions, assertions, and findings contained herein are those of the authors and should not be
construed as official U.S. Department of Defense or Department of the Army positions, policies, or decisions
unless so designated by other documentation.
